Abstract: A cardholder authentication method includes receiving, at an authentication network, an authentication request involving an account. The method further includes determining, based at least in part on a portion of an account identifier associated with said account, an authentication service. In addition, the method includes determining, based at least on said authentication service and a portion of said account identifier, an authentication response. The method also includes transmitting, to a merchant associated with a transaction involving said account, said authentication response.

Abstract: An AV sensor can be cleaned by charging a conductive layer over a sensor surface. The conductive layer may be positively or negatively charged and can repel contaminants having the same polarity away from the sensor. The charging of the conductive layer can be triggered by a determination that the sensor needs cleaning, which can be based on sensor data captured by the sensor or a different sensor. The charging of the conductive layer may include one or more charging cycles, each of which includes charging the conductive layer with two opposing polarities. Another conductive layer may be over the conductive layer. The other conductive layer can be charged with an opposite polarity from the conductive layer so that an electric field is present between the two conductive layers. A piezoelectric layer between the two conductive layers can vibrate under the electric field. The vibration can enhance the cleaning.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: A method of authenticating a video streaming transmission comprising generating a secure token at an application server, providing the secure token to a user device, receiving the secure token at a media server with a publish request from the user device, transmitting the secure token to the application server for authentication, and authenticating the secure token. The publish request from the user device is enabled if the secure token is authenticated by the application server. The connection between the media server and the user device is terminated if the secure token fails to authenticate.

Abstract: A method of authenticating a video streaming transmission comprising generating a secure token at an application server, providing the secure token to a user device, receiving the secure token at a media server with a publish request from the user device, transmitting the secure token to the application server for authentication, and authenticating the secure token. The publish request from the user device is enabled if the secure token is authenticated by the application server. The connection between the media server and the user device is terminated if the secure token fails to authenticate.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: The present invention relates to systems and methods that provide a portal user with role-based access to components on a network via portlets within the portal. The role-based access can be sharable such that one or more users with a similar role can instantiate instances of a shared portal. Sharable configurations can be stored local to the user's portal, local to another portal and/or within a networked storage medium. The access provides a user with an entry-point to components, wherein a user can monitor and control components. The user can additionally configure the portal such that the component access is further based on the user's location. Advantages of the present invention include delineation of access and administrative functionality, the ability to combine web and application servers within a similar environment, and the ability to access (e.g., controlling, collecting and analyzing data, etc.) when the user is not utilizing the portal.

Abstract: The present invention comprises an antimicrobial composition. More particularly to an antimicrobial composition that comprises a. from about 0.01% to about 15% of at least one non-anionic surfactant, by weight of the composition; b. from about 0.01% to about 15% of at least one acid, by weight of the composition; c. from about 0% to about 99.85% of water, by weight of the composition; and wherein the composition is foaming.

Abstract: The small particle liposome aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes. The liposomes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: Provided herein is a method of treating primary lung cancer or metastatic cancer to the lung in an individual by delivering at least once to the respiratory tract of the individual via inhalation a nebulized liposomal aerosol comprising a dilauroylphosphatidylcholine liposome containing camptothecin or a derivative thereof in an amount sufficient to deliver a pharmacologically effective dose of the camptothecin or its derivative to treat the cancer. Also provided is a nebulized liposomal aerosol comprising the DLPC containing the camptothecin or its derivative and a method of making the liposome-drug comprising the aerosol.

Abstract: Provided herein is a method of treating primary lung cancer or metastatic cancer to the lung in an individual by delivering at least once to the respiratory tract of the individual via inhalation a nebulized liposomal aerosol comprising a dilauroylphosphatidylcholine liposome containing camptothecin or a derivative thereof in an amount sufficient to deliver a pharmacologically effective dose of the camptothecin or its derivative to treat the cancer. Also provided is a nebulized liposomal aerosol comprising the DLPC containing the camptothecin or its derivative and a method of making the liposome-drug comprising the aerosol.

Abstract: The small particle liposome aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes. The liposomes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: Provided herein is a method of treating primary lung cancer or metastatic cancer to the lung in an individual by delivering at least once to the respiratory tract of the individual via inhalation a nebulized liposomal aerosol comprising a dilauroylphosphatidylcholine liposome containing camptothecin or a derivative thereof in an amount sufficient to deliver a pharmacologically effective dose of the camptothecin or its derivative to treat the cancer. Also provided is a nebulized liposomal aerosol comprising the DLPC containing the camptothecin or its derivative and a method of making the liposome-drug comprising the aerosol.

Abstract: This Simplified Self Powered Attitude Survival Indicator, provides a simple indicator which gives a visual indication of aircraft attitude and provides suitable indicators and alarms when needed. No vacuum or powered gyroscopes are used. The indicator is self powered and readily transportable from one aircraft to another. This invention is not used to replace the standard gyroscopic indicator, but to supplement it.

Abstract: The small particle liposome aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes. The liposomes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: A new type of polymer is described that represents a new composition of matter. This polymer contains alternating electronegative group III-VI elements connected with hydrocarbon or fluorocarbon linkages to form a polyalkyl or polyfluoroalkyl heteroatomic polymer. These polymers can be combined with lithium salts to form a solid polymer electrolyte for use in electrochemical systems such as batteries. These new solid polymer electrolytes exhibit lithium cation diffusion and lithium cation transport numbers that are superior to similar solid polymer electrolytes composed of polyethylene oxide.

Abstract: The present invention provides a method of inhibiting growth of lung metastases in an individual comprising the steps of administering in a combination an aerosolized polyethylenimine-DNA complex and an aerosolized liposome-anticancer drug complex with both of the complexes delivered via aerosolization. Delivery of both the DNA and the anticancer drug via this method inhibits growth of lung metastases in the individual. Also provided is a method of inhibiting growth of lung metastases in an individual by the administration in combination via aerosolization of a polyethylenimine-p53 complex and a dilauroylphosphatidylcholine-9-nitrocamptothecin complex.

Abstract: A new type of polymer is described that represents a new composition of matter. This polymer contains alternating electronegative group III-VI elements connected with hydrocarbon or fluorocarbon linkages to form a polyalkyl or polyfluoroalkyl heteroatomic polymer. These polymers can be combined with lithium salts to form a solid polymer electrolyte for use in electrochemical systems such as batteries. These new solid polymer electrolytes exhibit lithium cation diffusion and lithium cation transport numbers that are superior to similar solid polymer electrolytes composed of polyethylene oxide.